Constructive state utility rate regulation allows NiSource to collect a return of and a return on the bulk of its investments within 18 months, enhancing cash flow.

Q4 2024 Management View CEO Richard Pops highlighted 2024 as a transformative year focused on profitability and pipeline development, achieving over $1.5 billion in revenue and $450 million in EBITDA ...

The company is expecting 2025 EPS to range from $15.25 to $16.25, below the $16.33 FactSet consensus. Revenue is expected to decline by a mid-single-digit percent on a constant currency basis, as ...

Biogen expects 2025 non-GAAP EPS of $15.25-$16.25 and a mid-single-digit decline in total revenue, primarily due to MS franchise pressures, including potential biosimilar and generic entries. Growth ...

The funding agreement comes as Biogen revealed a modest Q4 sales beat, which analysts expect will be “overshadowed” by the ...

Vertiv is projecting another year of sales growth as the bustling data center market continues to provide it with strong pipeline activity.

Elliott Investment Management confirms a more than $2.5B stake in Phillips 66 and will seek to streamline the company, most ...

One of the most significant news items involving Vertex isn't reflected in the company's numbers just yet. Vertex's non-opioid pain relief drug, Journavx, received FDA approval on Jan. 30. The drug is ...

Legislation would close the loophole in California's pet retail ban by prohibiting brokers from selling or shipping dogs to ...